Testing Psychosocial Treatment Planning Methods for Youth Anxiety and Depression
| Status: | Active, not recruiting |
|---|---|
| Conditions: | Anxiety, Depression, Depression |
| Therapuetic Areas: | Psychiatry / Psychology |
| Healthy: | No |
| Age Range: | 7 - 15 |
| Updated: | 10/27/2018 |
| Start Date: | October 4, 2016 |
| End Date: | November 27, 2019 |
Personalizing Treatment Through Shared Decision Making for Youth Psychotherapy
Youth depression and anxiety represent a serious public health concern, with affected youth
often experiencing social, familial, and academic impairment. Research evidence supports a
growing array of effective treatments for youth depression and anxiety, yet as the collection
of evidence-based treatments expands, so do the challenges of utilizing the evidence:
clinicians must be able to (1) access, integrate, and apply the available evidence, and (2)
engage in a collaborative process with each family to develop a plan that is responsive to
each family's unique characteristics, preferences, and goals. Engaging caregivers and youths
as active collaborators in the treatment planning process is a patient-centered approach with
the potential to improve the process and outcome of youth mental health care by facilitating
the personalization of established evidence-based treatment approaches. Such collaboration,
frequently referred to as shared decision-making (SDM), is a hallmark of evidence-based
practice and a key feature of federal guidelines for health care delivery. However, despite
growing rhetorical support for SDM, empirical support is lacking, particularly in the area of
youth mental health treatment. The absence of such research is unfortunate, given the
potential for SDM to facilitate the dissemination and implementation of evidence-based
treatments, and to personalize the use of established treatments to increase acceptability,
retention, satisfaction, and overall effectiveness.
The present project tests the feasibility and acceptability of SDM through a pilot randomized
controlled trial of 40 youths (ages 7-15) meeting diagnostic criteria for an anxiety or
depressive disorder. The trial will compare an evidence-based treatment that is planned
collaboratively with youths and caregivers using the SDM protocol, to an evidence-based
treatment that is planned by the clinician and supervisor using pretreatment assessment data.
Eligible youths will received up to 26 treatment sessions at no cost and complete assessments
prior to the start of treatment, at the end of treatment, and six months following the end of
treatment.
often experiencing social, familial, and academic impairment. Research evidence supports a
growing array of effective treatments for youth depression and anxiety, yet as the collection
of evidence-based treatments expands, so do the challenges of utilizing the evidence:
clinicians must be able to (1) access, integrate, and apply the available evidence, and (2)
engage in a collaborative process with each family to develop a plan that is responsive to
each family's unique characteristics, preferences, and goals. Engaging caregivers and youths
as active collaborators in the treatment planning process is a patient-centered approach with
the potential to improve the process and outcome of youth mental health care by facilitating
the personalization of established evidence-based treatment approaches. Such collaboration,
frequently referred to as shared decision-making (SDM), is a hallmark of evidence-based
practice and a key feature of federal guidelines for health care delivery. However, despite
growing rhetorical support for SDM, empirical support is lacking, particularly in the area of
youth mental health treatment. The absence of such research is unfortunate, given the
potential for SDM to facilitate the dissemination and implementation of evidence-based
treatments, and to personalize the use of established treatments to increase acceptability,
retention, satisfaction, and overall effectiveness.
The present project tests the feasibility and acceptability of SDM through a pilot randomized
controlled trial of 40 youths (ages 7-15) meeting diagnostic criteria for an anxiety or
depressive disorder. The trial will compare an evidence-based treatment that is planned
collaboratively with youths and caregivers using the SDM protocol, to an evidence-based
treatment that is planned by the clinician and supervisor using pretreatment assessment data.
Eligible youths will received up to 26 treatment sessions at no cost and complete assessments
prior to the start of treatment, at the end of treatment, and six months following the end of
treatment.
Inclusion Criteria:
- a current DSM-5 principal diagnosis of a Major Depressive Disorder, Dysthymic
Disorder, Generalized Anxiety Disorder, Separation Anxiety Disorder, Social Phobia, or
Specific Phobia
- if receiving psychiatric medication, dose will be stable for at least 3 months at
enrollment with ability to maintain medication
- youth and caregiver speak fluent English
Exclusion Criteria:
- active suicidality
- history of severe physical or mental impairments (e.g., mental retardation, autism
spectrum disorders) in youth or caregiver
- participation in additional psychosocial treatment
We found this trial at
1
site
Boston University Boston University is no small operation . With over 33,000 undergraduate and graduate...
Click here to add this to my saved trials
